AI assistant
Sending…
Lotus Pharm — Director's Dealing 2017
Apr 5, 2017
51923_rns_2017-04-05_c98a4a26-7932-438e-ab29-9281b492cb94.html
Director's Dealing
Open in viewerOpens in your device viewer
公開資訊觀測站
資料期間為 106/04/05 至 106/04/05
| 公司代號 | 公司名稱 | 設質人身份別 | 設質人姓名 | 質設異動發生日期 | 設質股數 | 解質股數 | 累積質設股數 | 質權人姓名 | 備註 | 申報日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1795 | 美時 | A00010 董事長本人 |
香港商ALVOGEN EMERGING MARKETS HOLDINGS LIMITED | 106/04/05 | 0 | 75,550,000 | 0 | Morgan Stanley Senior Funding,Inc. | 106/04/05 |
More from Lotus Pharm
Capital/Financing Update
2026
May 21
Regulatory Filings
2026
May 21
Investor Presentation
2026
May 15
Investor Presentation
2026
May 15
Investor Presentation
2026
May 15
Proxy Solicitation & Information Statement
2026
May 15
AGM Information
2026
May 15
Proxy Solicitation & Information Statement
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14